Optimizing the Identification of HER2-Low Breast Cancer
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice.
CME information and select publications here.
You May Also Like
IQ - Wissenschaft und Forschung
Bayerischer Rundfunk
Aha! Zehn Minuten Alltags-Wissen
WELT
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
The Micah Hanks Program
Micah Hanks
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Filosofía, Psicología, Historias
Hernán Melana
Eye On The Sky
Vermont Public
Tommy Cullum's Let's Get Freaky
Tommy Cullum
AI Talks with Bone & Joint
AI Talks with Bone & Joint
IQ - Wissenschaft und Forschung
Bayerischer Rundfunk
Aha! Zehn Minuten Alltags-Wissen
WELT
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
The Micah Hanks Program
Micah Hanks
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Filosofía, Psicología, Historias
Hernán Melana
Eye On The Sky
Vermont Public
Tommy Cullum's Let's Get Freaky
Tommy Cullum
AI Talks with Bone & Joint
AI Talks with Bone & Joint
Community discussion